Today: 2 May 2026
IBM stock price dives after Anthropic’s COBOL AI tool rattles Wall Street — what to watch next
24 February 2026
2 mins read

IBM stock price dives after Anthropic’s COBOL AI tool rattles Wall Street — what to watch next

New York, Feb 23, 2026, 19:26 EST — After-hours

  • IBM shares dropped after hours as Anthropic rolled out a tool designed to update COBOL code.
  • Investors zeroed in on the question of AI automation—and whether it might squeeze fees linked to legacy system upgrades.
  • Traders are watching for company statements, plus the next round of big tech earnings reports.

IBM shares slid roughly 13% to $223.35 in late trading Monday, following news that Anthropic, the AI startup, introduced a tool targeting faster COBOL software modernization. Earlier, the stock changed hands between $255.77 and $221.00, with volume hitting about 19.5 million shares.

The market’s AI narrative has turned, making this selloff significant. Now, investors aren’t simply chasing AI-driven growth—they’re also pulling back from companies at risk of automation.

IBM falls into that second category—somewhat uncomfortably. The company’s business centers on steady, legacy enterprise systems work, exactly the sort of slow-moving projects now in the crosshairs of new code-writing tools.

Anthropic’s Claude Code is pitching automation for the “discovery” slog in legacy upgrades—meaning, it parses through old code to figure out what’s actually happening before developers jump in to update it. The company claims its tool can drag COBOL systems into the present “in quarters instead of years.” COBOL, still holding up the guts of U.S. banking, air travel, and government IT, processes about 95% of American ATM transactions, according to Anthropic. Shares of consulting majors Accenture and Cognizant each dropped roughly 6% on the day, per Investing.com. Investing.com

The issue for IBM boils down to this: fewer people on staff translates directly into a drop in billable hours. Clients eager to speed up rewrites and migrations are likely to push for lower prices, and they might cut back on the number of external teams they hire.

Wall Street took a hit, with the Dow dropping 1.66%, the S&P 500 off 1.04%, and the Nasdaq down 1.13%. Investors wrestled with tariff jitters and another AI scare, according to Reuters. “Sell first, assess later,” summed up Tom Hainlin, national investment strategist at U.S. Bank Wealth Management, describing how trading has moved on AI headlines. Reuters

Some of the selling pressure is automatic. Once investors begin to tag software and services as possible “AI losers,” companies tied closely to enterprise spending and consulting get trimmed from portfolios first.

IBM hasn’t let up on pushing its growth story. For the fourth quarter, software revenue climbed to $9.0 billion, a 14% gain. Infrastructure sales jumped 21%, thanks in large part to a 67% spike from IBM Z mainframes. CEO Arvind Krishna said the firm’s generative AI “book of business” now exceeds $12.5 billion. IBM Newsroom

Still, just because tools like Claude Code exist doesn’t mean they’re speeding up real-world buying decisions—at least, not yet. Major COBOL migrations remain bogged down by operational risks, regulatory scrutiny, and lengthy testing phases. Even if AI handles the initial work, people stick around to check the results.

IBM’s on the docket at the Morgan Stanley Technology, Media and Telecom Conference, set for March 3, with its first-quarter earnings penciled in for April 22, according to the company’s preliminary schedule.

Stock Market Today

  • Raymond James Raises Price Target for Precision Drilling Stock to C$165
    May 1, 2026, 9:48 PM EDT. Raymond James Financial raised its price target for Precision Drilling (TSE:PD) from C$162 to C$165, signaling a potential 27.46% upside. The firm holds an "outperform" rating. Other brokers like ATB Cormark and BMO Capital Markets also lifted targets, with ATB Cormark setting a new high of C$175. The stock trades around C$129.45, up 2.2%, with a market cap of C$1.68 billion. Precision Drilling recently reported quarterly EPS of C$1.34 and revenue of C$526 million. The company offers advanced drilling services, leveraging digital tech known as Alpha for operational efficiency. Market consensus leans toward a "Moderate Buy" with an average price target of C$152.25, reflecting optimism amid steady performance.

Latest article

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

US Stock Market Today After Hours: Nasdaq Tops 25,000 As S&P 500 Hits Record High

2 May 2026
Nasdaq 100 futures climbed 0.68% and S&P 500 futures edged up 0.06% in early after-hours trading Friday, while Dow futures slipped 0.48%. The S&P 500 and Nasdaq closed at record highs, driven by first-quarter S&P 500 profit growth of 27.8%, according to LSEG. Oil prices, inflation signals, and upcoming jobs data remain in focus. GameStop shares rose 4% after reports it was preparing an offer for eBay.
McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

McDonald’s Corporation Stock Slides Before Earnings as Its Big Drink Bet Comes Due

2 May 2026
McDonald’s shares fell 2.37% to $286.64 on Friday, underperforming rivals ahead of its May 7 earnings report and a U.S. launch of six new McCafé specialty drinks. The company will begin selling the drinks nationwide on May 6, adding beverage specialist roles at 14,000 restaurants. Investors are watching whether the new drinks and value offers can boost traffic without slowing service or hurting margins.
Strategy Inc’s 11.5% STRC Payout Sets Up Bitcoin Dividend Vote

Strategy Inc’s 11.5% STRC Payout Sets Up Bitcoin Dividend Vote

2 May 2026
Strategy Inc kept STRC’s May dividend rate at 11.5% and set a $0.958333333 per-share payout, according to a new filing. Shareholders are voting on whether to move STRC dividends from monthly to twice monthly, with results due at the June 8 annual meeting. The company recently used $255 million from a stock sale to buy 3,273 bitcoin.
Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod
Previous Story

Eli Lilly stock pops after Novo trial miss, new Zepbound pen gets FDA nod

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

Stock Market Today 24.02.2026

Go toTop